nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma.

MLA

Johnson, Kai C. C., et al. “Nab-Paclitaxel-Based Induction Chemotherapy Followed by Cisplatin and Radiation Therapy for Human Papillomavirus-Unrelated Head and Neck Squamous-Cell Carcinoma.” Medical Oncology, vol. 36, no. 11, Nov. 2019, p. N.PAG. EBSCOhost, https://doi.org/10.1007/s12032-019-1318-5.

APA

Johnson, K. C. C., Ley, J., Oppelt, P., Lu, J., Gay, H. A., Daly, M., Jackson, R., Rich, J., Pipkorn, P., Paniello, R. C., Zevallos, J., Thorstad, W., & Adkins, D. R. (2019). nab-Paclitaxel-based induction chemotherapy followed by cisplatin and radiation therapy for human papillomavirus-unrelated head and neck squamous-cell carcinoma. Medical Oncology, 36(11), N.PAG. https://doi.org/10.1007/s12032-019-1318-5

Chicago

Johnson, Kai C. C., Jessica Ley, Peter Oppelt, Jingxia Lu, Hiram A. Gay, Mackenzie Daly, Ryan Jackson, et al. 2019. “Nab-Paclitaxel-Based Induction Chemotherapy Followed by Cisplatin and Radiation Therapy for Human Papillomavirus-Unrelated Head and Neck Squamous-Cell Carcinoma.” Medical Oncology 36 (11): N.PAG. doi:10.1007/s12032-019-1318-5.